Tiffany Reiter is an Associate in the Boston office of Fish & Richardson. Dr. Reiter’s practice emphasizes U.S. and foreign patent prosecution, opinion work, due diligence studies, and portfolio advisement.
Technical areas of Dr. Reiter’s prosecution and opinion work include molecular biology, biochemistry and biochemical pathways, genetics, cellular biology, virology, recombinant protein manufacturing, nucleic acid vectors and RNAi, chromatin remodeling, array technology, immunology, recombinant antibody screening and engineering, molecular medicine, screening and diagnostic assays and kits, biomarkers, transgenic plants and animals, cell lines, nanoparticle technology, surgical procedures, vaccines, and neuroscience.
Dr. Reiter has over seven years of patent prosecution experience in the life sciences. She has research experience as a post-doctoral fellow at the Harvard School of Public Health where she worked on a project combining the fields of neuroscience, molecular biology, and biochemistry; an intern at Northrup King where she worked on transgenic plant research; and as a student at the Mayo Graduate School where she studied the redox regulation of metalloenzymes using molecular biology, cellular biology, biochemistry, and a variety of spectroscopic methods.
March 31, 2016
Fish & Richardson Attorney, Dr. Tiffany Reiter, Selected for Leadership Council on Legal Diversity 2016 Pathfinder Program
November 14, 2012
Fish hosts entrepreneurs from Global Innovation through Science & Technology (GIST)
May 8, 2012
The America Invents Act and Its Importance to Patent Prosecution in the Biotech Sector